第 1 到 35 筆結果,共 35 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19 | Fang, Jia-You; Huang, Kuo-Yen; Wang, Tong-Hong; Lin, Zih-Chan; Chen, Chin-Chuan; SUI-YUAN CHANG ; Chen, En-Li; TAI-LING CHAO ; Yang, Shuenn-Chen; PAN-CHYR YANG ; Chen, Chi-Yuan | Journal of nanobiotechnology | |||
2 | 2023 | Dual Effects of 3-epi-betulin from Daphniphyllum glaucescens in Suppressing SARS-CoV-2-Induced Inflammation and Inhibiting Virus Entry | Yeh, Yung-Ju; TAI-LING CHAO ; Chang, Yu-Jen; SUI-YUAN CHANG ; Lu, Chih-Hao; Chao, Chih-Hua; Su, Wen-Chi; Tseng, Ching-Ping; Lai, Michael M C; Cheng, Ju-Chien | International journal of molecular sciences | |||
3 | 2023 | Synthesis, evaluation, and mechanism of 1-(4-(arylethylenylcarbonyl)phenyl)-4-carboxy-2-pyrrolidinones as potent reversible SARS-CoV-2 entry inhibitors | Palla, Srinivasa Rao; Li, Chen-Wei; TAI-LING CHAO ; Lo, Hoi-Ling Vienn; Liu, Jia-Jin; Pan, Max Yu-Chen; Chiu, Yu-Ting; Lin, Wen-Chin; Hu, Chih-Wei; Yang, Chuen-Mi; Chen, Yi-Ying; Fang, Jun-Tung; Lin, Sheng-Wei; Lin, Yi-Tzu; Lin, Hsiao-Ching; Kuo, Chih-Jung; Wang, Lily Hui-Ching; SUI-YUAN CHANG ; Liang, Po-Huang | Antiviral research | 0 | 0 | |
4 | 2023 | The Src-ZNRF1 axis controls TLR3 trafficking and interferon responses to limit lung barrier damage | Lin, You-Sheng; Chang, Yung-Chi; TAI-LING CHAO ; Tsai, Ya-Min; Jhuang, Shu-Jhen; Ho, Yu-Hsin; Lai, Ting-Yu; Liu, Yi-Ling; Chen, Chiung-Ya; Tsai, Ching-Yen; Hsueh, Yi-Ping; SUI-YUAN CHANG ; Chuang, Tsung-Hsien; CHIH-YUAN LEE ; LI-CHUNG HSU | The Journal of experimental medicine | 0 | 0 | |
5 | 2023 | Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19 | WANG-DA LIU ; JANN-TAY WANG ; TAI-LING CHAO ; Ieong, Si-Man; Tsai, Ya-Min; Kuo, Po-Hsien; MING-JUI TSAI ; Chen, Yi-Jie; Li, Guei-Chi; Ho, Shu-Yuan; Chen, Hui-Hou; YU-SHAN HUANG ; CHIEN-CHING HUNG ; YEE-CHUN CHEN ; SUI-YUAN CHANG ; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
6 | 2023 | Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin | Yang, Cheng-Wei; Hsu, Hsing-Yu; Lee, Yue-Zhi; Jan, Jia-Tsrong; SUI-YUAN CHANG ; Lin, Yi-Ling; Yang, Ruey-Bing; TAI-LING CHAO ; Liang, Jian-Jong; Lin, Shu-Jing; Liao, Chun-Che; Chang, Chih-Shin; Sytwu, Huey-Kang; Hung, Ming-Shiu; Chen, Chiung-Tong; Lee, Shiow-Ju | Biochemical pharmacology | 2 | 1 | |
7 | 2023 | Isolation of Anti-SARS-CoV-2 Natural Products Extracted from Mentha canadensis and the Semi-synthesis of Antiviral Derivatives | Chou, Osbert; Juang, Yu-Pu; TAI-LING CHAO ; Tsai, Sheng-Fa; Chiu, Pei-Fang; Chiou, Chun-Tang; Tsai, Keng-Chang; SUI-YUAN CHANG ; PI-HUI LIANG ; Wong, Chi-Huey | Journal of natural products | 3 | 0 | |
8 | 2023 | Elicitation of potent neutralizing antibodies in obese mice by ISA 51-adjuvanted SARS-CoV-2 spike RBD-Fc vaccine | Li, Chia-Jung; Jiang, Chung-Lin; TAI-LING CHAO ; Lin, Shiau-Yu; Tsai, Ya-Min; Chao, Chong-Syun; Su, Yu-Ting; Chen, Chun-Jen; SUI-YUAN CHANG ; FU-JUNG LIN ; SHIH-CHUNG CHANG | Applied microbiology and biotechnology | 1 | 1 | |
9 | 2023 | IFN-stimulated metabolite transporter ENT3 facilitates viral genome release | Hsieh, Yu-Ting; Tsai, Tsung-Lin; Huang, Shen-Yan; Heng, Jian-Wen; Huang, Yu-Chia; Tsai, Pei-Yuan; Tu, Chia-Chun; TAI-LING CHAO ; Tsai, Ya-Min; Chang, Pei-Ching; CHIEN-KUO LEE ; Yu, Guann-Yi; SUI-YUAN CHANG ; Dzhagalov, Ivan L; Hsu, Chia-Lin | EMBO Reports | 0 | 0 | |
10 | 2023 | Clinical assessment of SARS-CoV-2 infectivity by rapid antigen test compared with virus isolation | TAI-LING CHAO ; Lee, Wen-Hau; Hu, Hui-Chun; Lin, Yi-Chun; Ho, Shu-Yuan; Chen, Hui-Hou; Chen, Cheng-Pin; Tsai, Ya-Min; Fang, Jun-Tung; Leong, Si-Man; Cheng, Yu-Chen; Peng, Mavis; Cheng, Shu-Hsing; Cheng, Chien-Yu; SUI-YUAN CHANG | Journal of clinical virology plus | 2 | 1 | |
11 | 2023 | Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccine | WANG-HUEI SHENG ; Ieong, Si-Man; Lin, Pin-Hung; MING-JU HSIEH ; HUNG-CHIH YANG ; Pan, Ching-Fu; TAI-LING CHAO ; SUI-YUAN CHANG ; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association = Taiwan yi zhi | 7 | 4 | |
12 | 2023 | Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511 | Lee, Yue-Zhi; Hsu, Hsing-Yu; Yang, Cheng-Wei; Lin, Yi-Ling; SUI-YUAN CHANG ; Yang, Ruey-Bing; Liang, Jian-Jong; TAI-LING CHAO ; Liao, Chun-Che; Kao, Han-Chieh; Chang, Jang-Yang; Sytwu, Huey-Kang; Chen, Chiung-Tong; Lee, Shiow-Ju | Pharmaceutics | 0 | 0 | |
13 | 2022 | Simultaneous detection of antibody responses to multiple SARS-CoV-2 antigens by a Western blot serological assay | Hsiao, Chia-Chun; Chiang, Yi-Wei; TAI-LING CHAO ; Tsai, Zen-Uong; Wang, Ting-Xuan; Jiang, Yu-Wei; Hsu, Hsiang-Fu; Lu, De-Chao; JANN-TAY WANG ; Wang, Jen-Ren; AN-BANG WANG ; SUI-YUAN CHANG ; SHIH-CHUNG CHANG | Applied microbiology and biotechnology | 0 | 0 | |
14 | 2022 | Tag-Free SARS-CoV-2 Receptor Binding Domain (RBD), but Not C-Terminal Tagged SARS-CoV-2 RBD, Induces a Rapid and Potent Neutralizing Antibody Response | Lin, Ting-Wei; Huang, Ping-Han; Liao, Bo-Hung; TAI-LING CHAO ; Tsai, Ya-Min; SHIH-CHUNG CHANG ; SUI-YUAN CHANG ; HUI-WEN CHEN | Vaccines | 5 | 4 | |
15 | 2022 | The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b | Lee, Yue-Zhi; Hsu, Hsing-Yu; Yang, Cheng-Wei; Lin, Yi-Ling; SUI-YUAN CHANG ; Yang, Ruey-Bing; Liang, Jian-Jong; TAI-LING CHAO ; Liao, Chun-Che; Kao, Han-Chieh; Chang, Jang-Yang; Sytwu, Huey-Kang; Chen, Chiung-Tong; Lee, Shiow-Ju | Pharmaceutics | 2 | 2 | |
16 | 2022 | Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2 | Juang, Yu-Pu; Chou, Yu-Ting; Lin, Ru-Xian; Ma, Hsiu-Hua; TAI-LING CHAO ; Jan, Jia-Tsrong; SUI-YUAN CHANG ; PI-HUI LIANG | European journal of medicinal chemistry | 9 | ||
17 | 2022 | A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant | Chang, Yi-Chung; Yang, Chi-Fan; Chen, Yi-Fen; Yang, Chia-Chun; Chou, Yuan-Lin; Chou, Hung-Wen; Chang, Tein-Yao; TAI-LING CHAO ; Hsu, Shu-Chen; Ieong, Si-Man; Tsai, Ya-Min; Liu, Ping-Cheng; Chin, Yuan-Fan; Fang, Jun-Tung; Kao, Han-Chieh; Lu, Hsuan-Ying; Chang, Jia-Yu; Weng, Ren-Shiuan; Tu, Qian-Wen; Chang, Fang-Yu; Huang, Kuo-Yen; Lee, Tong-Young; SUI-YUAN CHANG ; PAN-CHYR YANG | EMBO molecular medicine | 21 | 17 | |
18 | 2022 | Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models | Huang, Han-Yi; Liao, Hsin-Yu; Chen, Xiaorui; Wang, Szu-Wen; Cheng, Cheng-Wei; Shahed-Al-Mahmud, Md; Liu, Yo-Min; Mohapatra, Arpita; Chen, Ting-Hua; Lo, Jennifer M; Wu, Yi-Min; Ma, Hsiu-Hua; Chang, Yi-Hsuan; Tsai, Ho-Yang; Chou, Yu-Chi; Hsueh, Yi-Ping; Tsai, Ching-Yen; Huang, Pau-Yi; SUI-YUAN CHANG ; TAI-LING CHAO ; Kao, Han-Chieh; Tsai, Ya-Min; Chen, Yen-Hui; Wu, Chung-Yi; Jan, Jia-Tsrong; Cheng, Ting-Jen Rachel; Lin, Kuo-I; Ma, Che; Wong, Chi-Huey | Science translational medicine | 62 | 54 | |
19 | 2022 | Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2 | Lee, Richard Kuan-Lin; Li, Tian-Neng; SUI-YUAN CHANG ; TAI-LING CHAO ; Kuo, Chun-Hsien; Pan, Max Yu-Chen; Chiou, Yu-Ting; Liao, Kuan-Ju; Yang, Yi; Wu, Yi-Hsuan; Huang, Chen-Hao; HSUEH-FEN JUAN ; Hsieh, Hsing-Pang; Wang, Lily Hui-Ching | International journal of molecular sciences | 13 | 13 | |
20 | 2022 | Neutralization or enhancement of SARS-CoV-2 infection by a monoclonal antibody targeting a specific epitope in the spike receptor-binding domain | Lai, Guan Chun; TAI-LING CHAO ; Lin, Shiau Yu; Kao, Han Chieh; Tsai, Ya Min; Lu, De Chao; Chiang, Yi Wei; SUI-YUAN CHANG ; SHIH-CHUNG CHANG | Antiviral Research | 3 | 3 | |
21 | 2022 | Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion | Li, Chia Jung; TAI-LING CHAO ; Chang, Ting Yu; Hsiao, Chia Chun; Lu, De Chao; Chiang, Yi Wei; Lai, Guan Chun; Tsai, Ya Min; Fang, Jun Tung; Ieong, Siman; JANN-TAY WANG ; SUI-YUAN CHANG ; SHIH-CHUNG CHANG | Microbiology Spectrum | 9 | 5 | |
22 | 2022 | Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination | WANG-HUEI SHENG ; SUI-YUAN CHANG ; Lin, Pin-Hung; MING-JU HSIEH ; HAO-HSIANG CHANG ; Cheng, Chien-Yu; HUNG-CHIH YANG ; Pan, Ching-Fu; Ieong, Si-Man; TAI-LING CHAO ; Chen, Jang-Pin; Cheng, Shu-Hsing; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association = Taiwan yi zhi | 22 | 18 | |
23 | 2022 | Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets | Yu, Pei-Chen; Huang, Chen-Hao; Kuo, Chih-Jung; Liang, Po-Huang; Wang, Lily Hui-Ching; Pan, Max Yu-Chen; SUI-YUAN CHANG ; TAI-LING CHAO ; Ieong, Si-Man; Fang, Jun-Tung; Huang, Hsuan-Cheng; HSUEH-FEN JUAN | Pharmaceutics | 5 | 4 | |
24 | 2021 | Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19 | WANG-DA LIU ; CHIEN-CHING HUNG ; JANN-TAY WANG ; MING-JUI TSAI ; Kuo, Po-Hsien; TAI-LING CHAO ; SZU-MIN HSIEH ; WANG-HUEI SHENG ; YEE-CHUN CHEN ; SUI-YUAN CHANG ; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association = Taiwan yi zhi | 4 | 1 | |
25 | 2021 | D614g substitution of sars-cov-2 spike protein increases syncytium formation and virus titer via enhanced furin-mediated spike cleavage | Cheng, Ya Wen; TAI-LING CHAO ; Li, Chiao Ling; Wang, Sheng Han; Kao, Han Chieh; Tsai, Ya Min; HURNG-YI WANG ; Hsieh, Chi Ling; Lin, You Yu; PEI-JER CHEN ; SUI-YUAN CHANG ; Shiou-Hwei Yeh | mBio | 21 | 18 | |
26 | 2021 | Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection | Huang, Kuo-Yen; Lin, Ming-Shiu; Kuo, Ting-Chun; Chen, Ci-Ling; Lin, Chung-Chih; Chou, Yu-Chi; TAI-LING CHAO ; Pang, Yu-Hao; Kao, Han-Chieh; Huang, Rih-Sheng; Lin, Steven; SUI-YUAN CHANG ; PAN-CHYR YANG | EMBO Molecular Medicine | 41 | 32 | |
27 | 2021 | Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses | SUI-YUAN CHANG ; Huang, Kuo-Yen; TAI-LING CHAO ; Kao, Han-Chieh; Pang, Yu-Hao; Lu, Lin; Chiu, Chun-Lun; Huang, Hsin-Chang; Cheng, Ting-Jen Rachel; JIM-MIN FANG ; PAN-CHYR YANG | Scientific reports | 29 | 28 | |
28 | 2021 | Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2 | Kuo, Chih-Jung; TAI-LING CHAO ; Kao, Han-Chieh; Tsai, Ya-Min; Liu, Yi-Kai; Wang, Lily Hui-Ching; Hsieh, Ming-Chang; SUI-YUAN CHANG ; Liang, Po-Huang | Antimicrobial agents and chemotherapy | 27 | 22 | |
29 | 2021 | Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2 | Hsu, Hsing-Yu; Yang, Cheng-Wei; Lee, Yue-Zhi; Lin, Yi-Ling; SUI-YUAN CHANG ; Yang, Ruey-Bing; Liang, Jian-Jong; TAI-LING CHAO ; Liao, Chun-Che; Kao, Han-Chieh; Wu, Szu-Huei; Chang, Jang-Yang; Sytwu, Huey-Kang; Chen, Chiung-Tong; Lee, Shiow-Ju | Frontiers in pharmacology | 15 | 14 | |
30 | 2020 | Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19 | Huang, Chen-Tsung; TAI-LING CHAO ; Kao, Han-Chieh; Pang, Yu-Hao; Lee, Wen-Hau; Hsieh, Chiao-Hui; SUI-YUAN CHANG ; Huang, Hsuan-Cheng; Juan, H.-F. | Heliyon | 16 | 15 | |
31 | 2020 | Differentiation of cytopathic effects (CPE) induced by influenza virus infection using deep convolutional neural networks (CNN) | Wang T.-E.; TAI-LING CHAO ; Tsai H.-T.; Lin P.-H.; Tsai Y.-L.; SUI-YUAN CHANG | PLoS Computational Biology | 4 | 5 | |
32 | 2020 | Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects | Cheng, Ya-Wen; TAI-LING CHAO ; Li, Chiao-Ling; Chiu, Mu-Fan; Kao, Han-Chieh; Wang, Sheng-Han; Pang, Yu-Hao; Lin, Chih-Hui; Tsai, Ya-Min; Lee, Wen-Hau; Tao, Mi-Hua; Ho, Tung-Ching; Wu, Ping-Yi; Jang, Li-Ting; SUI-YUAN CHANG ; Shiou-Hwei Yeh ; PEI-JER CHEN | Cell reports | 167 | 160 | |
33 | 2020 | Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives | Yang, Cheng-Wei; Lee, Yue-Zhi; Hsu, Hsing-Yu; Jan, Jia-Tsrong; Lin, Yi-Ling; SUI-YUAN CHANG ; Peng, Tzu-Ting; Yang, Ruey-Bing; Liang, Jian-Jong; Liao, Chun-Che; TAI-LING CHAO ; Pang, Yu-Hau; Kao, Han-Chieh; Huang, Wen-Zheng; Lin, Jiunn-Horng; Chang, Chun-Ping; Niu, Guang-Hao; Wu, Szu-Huei; Sytwu, Huey-Kang; Chen, Chiung-Tong; Lee, Shiow-Ju | Frontiers in pharmacology | 17 | 15 | |
34 | 2020 | Characterization of Influenza A Virus Infection in Mouse Pulmonary Stem/Progenitor Cells | TAI-LING CHAO ; Gu S.-Y.; Lin P.-H.; Chou Y.-T.; THAI-YEN LING ; SUI-YUAN CHANG | Frontiers in Microbiology | 5 | 5 | |
35 | 2014 | Virological, serological, and antiviral studies in an imported human case of avian influenza A(H7N9) virus in Taiwan | Lin P.-H.; TAI-LING CHAO ; SHUENN-WEN KUO ; JANN-TAY WANG ; CHIEN-CHING HUNG ; Lin H.-C.; Yang Z.-Y.; Ho S.-Y.; Chang C.-K.; Huang M.-S.; Chen H.-H.; YEE-CHUN CHEN ; HONG-SHIEE LAI ; SUI-YUAN CHANG ; SHAN-CHWEN CHANG ; PAN-CHYR YANG | Clinical Infectious Diseases | 38 | 38 |